Osteointegration of hydroxyapatite-titanium implants coated with nonglycosylated recombinant human bone morphogenetic protein-2 (BMP-2) in aged sheep

被引:106
作者
Sachse, A
Wagner, A
Keller, M
Wagner, O
Wetzel, WD
Layher, F
Venbrocks, RA
Hortschansky, P
Pietrasnzyk, M
Wiederanders, B
Hempel, HJ
Bossert, J
Horn, J
Schmuck, K
Mollenhauer, J
机构
[1] Univ Jena, Waldkrankenhaus Rudolf Elle, Dept Orthopaed, D-07607 Jena, Germany
[2] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany
[3] Univ Jena, Fac Med, Dept Biochem, D-6900 Jena, Germany
[4] Univ Jena, Inst Mat Sci & Technol, D-6900 Jena, Germany
[5] DePuy Biotech GmbH, Jena, Germany
[6] Rush Med Coll, Dept Biochem, Chicago, IL 60612 USA
关键词
metal implant; bone growth; ovis ammon aries; aging; osteoporosis;
D O I
10.1016/j.bone.2005.06.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteointegration of metal implants into aged organisms can be severely compromised due to reduced healing capacity of bone, lack of precursor cells for new bone formation, or osteoporosis. Here, we report on successful implant healing in a novel model of aged sheep in the presence of nonglycosylated bone morphogenetic protein 2 (BMP-2). Ewes of 8 to 12 years with significant radiologic and histologic signs of osteoporosis and adipocytic bone marrow received a cylindrical hydroxyapatite-titanium implant of 12 x 10 mm. BMP-2 has been produced as a bacterial recombinant fusion protein with maltose-binding protein and in vitro generation of mature BMP-2 by renaturation and proteolytic cleavage. A BMP-2 inhibition ELISA was developed to measure the in vitro release kinetics of bioactive human BMP-2 from immersed solid implant materials by using Escherichia coli expressed and biotinylated recombinant human BMP-2 receptor IA extracellular domain (ALK-3 ECD). The implants were placed laterally below both tibial plateaus, with the left leg implant carrying 380 mu g BMP-2. Both implant types became integrated within the following 20 weeks. The control implant only integrated at the cortical bone, and little new bone formation was found within the pre-existing trabecular bone or the marrow cavity. Marrow fat tissue was partially replaced by unspecific connective tissue. In contrast, BMP-2-coated implants initiated significant new bone formation, initially in trabecular arrangements to be replaced by cortical-like bone after 20 weeks. The new bone was oriented towards the cylinder. Highly viable bone marrow appeared and filled the lacunar Structures of the new bone. In mechanical tests, the BMP-2-coated implants displayed in average 50% higher stability. This animal model provided first evidence that application of nonglycosylated BMP-2 coated on solid implants may foster bone healing and regeneration even in aged-compromised individuals. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:699 / 710
页数:12
相关论文
共 29 条
[1]   In vivo comparison of the osseointegration of vacuum plasma sprayed titanium- and hydroxyapatite-coated implants [J].
Aebli, N ;
Krebs, J ;
Stich, H ;
Schawalder, P ;
Walton, M ;
Schwenke, D ;
Gruner, H ;
Gasser, B ;
Theis, JC .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2003, 66A (02) :356-363
[2]  
COLE BJ, 1997, CLIN ORTHOP RELAT R, V345, P219
[3]  
COOK SD, 1988, CLIN ORTHOP RELAT R, V232, P225
[4]   Bone morphogenetic proteins act synergistically with haematopoietic cytokines in the differentiation of haematopoietic progenitors [J].
Detmer, K ;
Walker, AN .
CYTOKINE, 2002, 17 (01) :36-42
[5]   A METHOD FOR THE STUDY OF UNDECALCIFIED BONES AND TEETH WITH ATTACHED SOFT-TISSUES - THE SAGE-SCHLIFF (SAWING AND GRINDING) TECHNIQUE [J].
DONATH, K ;
BREUNER, G .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1982, 11 (04) :318-326
[6]   Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads [J].
Gründer, T ;
Gaissmaier, C ;
Fritz, J ;
Stoop, R ;
Hortschansky, P ;
Mollenhauer, J ;
Aicher, WK .
OSTEOARTHRITIS AND CARTILAGE, 2004, 12 (07) :559-567
[7]  
HORTSCHANSKY P, 2001, Patent No. 19944626
[8]   THE OVARIECTOMIZED RAT MODEL OF POSTMENOPAUSAL BONE LOSS [J].
KALU, DN .
BONE AND MINERAL, 1991, 15 (03) :175-191
[9]   BONE MORPHOGENETIC PROTEIN-2 CONVERTS THE DIFFERENTIATION PATHWAY OF C2C12 MYOBLASTS INTO THE OSTEOBLAST LINEAGE [J].
KATAGIRI, T ;
YAMAGUCHI, A ;
KOMAKI, M ;
ABE, E ;
TAKAHASHI, N ;
IKEDA, T ;
ROSEN, V ;
WOZNEY, JM ;
FUJISAWASEHARA, A ;
SUDA, T .
JOURNAL OF CELL BIOLOGY, 1994, 127 (06) :1755-1766
[10]   The impact of bone morphogenetic protein-2 (BMP-2), Vascular Endothelial Growth Factor (VEGF) and basic Fibroblast Growth Factor (b-FGF) on the osteointegration, the degradation and biomechanical properties of a synthetic bone substitute [J].
Kessler, S ;
Mayr-Wohlfart, U ;
Ignatius, A ;
Puhl, W ;
Claes, L ;
Günther, KP .
ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE, 2003, 141 (04) :472-480